Phase I study of intravenous (IV) milataxel in adult patients with advanced malignant tumors.

被引：0
|
作者：
Bourbouloux, E.
Campone, M.
Vermorken, J. B.
Martin, M.
Sessa, C.
Perotti, A.
机构：
[1] Univ Antwerp Hosp, Antwerp, Belgium
[2] Hosp Clin Univ San Carlos, Madrid, Spain
[3] Osped San Giovani, Bellinzona, Switzerland
[4] Ist Nazl Tumori, I-20133 Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：88S / 88S
页数：1
相关论文
共 50 条
  • [1] A phase I study of intravenous (IV) milataxel in combination with carboplatin in adult patients with advanced malignant solid tumors
    Flood, W. A.
    Lewis, L. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] A phase I study of intravenous artesunate (IV AS) in patients with solid tumors.
    Deeken, John F.
    Wang, Hongkun
    Smaglo, Brandon George
    Hwang, Jimmy J.
    He, Aiwu Ruth
    Weiner, Louis M.
    Marshall, John
    Giaccone, Giuseppe
    Liu, Stephen V.
    Luecht, Jim
    Urso, Christina
    Spiegel, Jay Y.
    Cheema, Amrita
    Pishvaian, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Phase I study of sapacitabine and seliciclib in patients with advanced solid tumors.
    Tolaney, Sara M.
    Hilton, John Frederick
    Cleary, James M.
    Gandhi, Leena
    Kwak, Eunice Lee
    Clark, Jeffrey W.
    Wolanski, Andrew
    Bell, Tracy Demeo
    Rodig, Scott J.
    Chiao, Judy H.
    Blake, David
    Shapiro, Geoffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] A phase I QTc study of tivozanib in patients with advanced solid tumors.
    Chadha, Manpreet Kaur
    Infante, Jeffrey R.
    Cotreau, Monette M.
    Jacobson, Lindsey
    Strahs, Andrew Louis
    Slichenmyer, William
    Vargo, Dennis
    Moore, Kathleen N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [5] Intravenous administration of ALKS 4230 as monotherapy and in combination with pembrolizumab in a phase I study of patients with advanced solid tumors.
    Vaishampayan, Ulka N.
    Fishman, Mayer N.
    Cho, Daniel C.
    Hoimes, Christopher J.
    Velcheti, Vamsidhar
    McDermott, David F.
    Slichenmyer, William J.
    Putiri, Emily
    Losey, Heather
    Rossi, Sean
    Ernstoff, Marc S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] A phase I study of doxorubicin in horses with advanced tumors.
    Theon, A. P.
    Magdesian, G. K.
    Pusterla, N.
    Wilson, W. D.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2007, 21 (03) : 667 - 667
  • [7] Phase I dose-finding study of BN80927 as an intravenous infusion every 21 days in patients with advanced malignant solid tumors.
    Lesimple, T.
    Bertheault-Cvitkovic, F.
    Delavault, P.
    Prevost, G.
    Fohanno, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Phase I study of ispinesib in combination with carboplatin in patients with advanced solid tumors.
    Jones, S. F.
    Plummer, E. R.
    Burris, H. A.
    Razak, A. R.
    Meluch, A. A.
    Bowen, C. J.
    Williams, D. H.
    Hodge, J. P.
    Dar, M. M.
    Calvert, A. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 85S - 85S
  • [9] Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumors.
    Hollebecque, Antoine
    Bahleda, Rastislav
    Thery, Jean Christophe
    Faivre, Laura
    Le Deley, Marie-Cecile
    Paci, Angelo
    Varga, Andrea
    Gazzah, Anas
    Massard, Christophe
    Poinsignon, Vianney
    Malekzadeh, Katty
    Ribrag, Vincent
    Angevin, Eric
    Postel-Vinay, Sophie
    Gomez-Roca, Carlos Alberto
    Gharib, Myriam
    Dufour, Fabienne
    Soria, Jean-Charles
    Spano, Jean-Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] Phase I study of MEDI0639 in patients with advanced solid tumors.
    Falchook, Gerald Steven
    Dowlati, Afshin
    Naing, Aung
    Gribbin, Matthew Joseph
    Jenkins, David William
    Chang, Linda L.
    Lai, Dominic W.
    Smith, David C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345